Humoral Immune Responses to Virus-like Particle Vaccine Candidates for RSV

RSV 病毒样颗粒疫苗候选物的体液免疫反应

• 批准号: 8297021
• 负责人: Trudy G. Morrison
• 金额: $ 41.13万
• 依托单位: UNIV OF MASSACHUSETTS MED SCH WORCESTER
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-08-01 至 2013-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8297021
• 关键词: Acute; Address; Adjuvant; Affinity; Animal Model; Antibodies; Antibody Formation; Antigens; Attenuated; B-Lymphocytes; Biological Models; Child; Chimeric Proteins; Cytoplasmic Tail; DNA Vaccines; Disease; Dose; Drug Formulations; Elderly; Elements; Exposure to; Failure; Formalin; GTP-Binding Proteins; Generations; Glycoproteins; Goals; Health; Human; Human respiratory syncytial virus; Humoral Immunities; IL2RA gene; Immune; Immune response; Immunization; Immunocompromised Host; Inactivated Vaccines; Indium; Individual; Infant; Knockout Mice; Knowledge; LIM Domain; Licensing; Life; Lung; Lung diseases; Membrane Proteins; Memory; Molecular Conformation; Mus; Natural Immunity; Nature; Newcastle disease virus; Nucleocapsid Proteins; Pathology; Plasma Cells; Population; Preparation; Proteins; Respiratory Syncytial Virus Vaccines; Respiratory Tract Infections; Respiratory syncytial virus; Respiratory syncytial virus RSV F proteins; Risk; Role; Safety; Simulate; Subunit Vaccines; System; Target Populations; Testing; Vaccine Research; Vaccines; Viral Antigens; Virus; Virus Diseases; Virus Replication; Virus-like particle; abstracting; base; burden of illness; design; insight; mouse model; neutralizing antibody; novel; novel vaccines; novel virus; particle; pathogen; research study; response; vaccine candidate; vaccine development; vector